TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of patients reaching transfusion independency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in CGI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number or occurrence of at least possibly related Grade 3 AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of AT-101 in combination with docetaxel and prednisone
Endpoint domain: Adverse events/effects
Primary endpoint: Erectile Function domain score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: fMRI (BOLD) responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total arterial flowrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long term occupational status
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: long term cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: long term quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mortality within 1 year of admission
Endpoint domain: Mortality/survival
Primary endpoint: Exacerbations within 1 year of admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between lumpectomy bed's center-of-mass (COM) as determined by USEI and CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with >30% reduction in neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in Crohn's Disease Activity Index (CDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted Geometric Mean Observed Serum Trough Concentration at Steady State (Cminss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Remission at Week 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Remission at Week 66
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient and parent satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glycated hemoglobin (HbA1c) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence and severity of ocular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence and severity of other adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Beck Depression Inventory II (BDI-II) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in r, k and MA-TEG parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary continence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease of total choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Troponin I elevation above the URL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total number of retrieved oocytes per cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Observer variability in scoring Vascular Calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of Participants With Serum HBV DNA < 400 Copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measured endogenous antimicrobial activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Measured levels of mediators of host defense, including defensins, cytokines, and chemokines in CVL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with neonatal complications
Endpoint domain: Mortality/survival
Primary endpoint: elevation of thumb capillary lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholelithiasis detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in DAPAR scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Radiographic examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: downstage rate of mediastinal lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants Who Reported Nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Change in asthma Control Status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glycated haemoglobin (HbA1c) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of subjects screened with AF identified at Index Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of subjects screened with AF not identified at Index Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dichotomy Index (I<O)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of 17-item Hamilton Rating Scale for Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline of Perceived Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Longitudinal change in body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Longitudinal change in fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Longitudinal change in glycosylated hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Longitudinal change in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of hyperoxia
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Insomnia Severity Index score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in health-related quality of life (HRQoL) instrument 15D score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants Experiencing Non-Major Adverse Cardiac Events (Non-MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Responders and Non-responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Medical Appointment Keeping
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in HIV Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Antiretroviral Treatment Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: General Health Questionnaire-12 (GHQ-12)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mucosal Impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who achieved complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Hand-Foot Syndrome (HFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oxygen Consumption (VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant Meaning Making Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: residual postoperative knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence rate of adverse events (AEs) after ARNUITY administration
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Forced Expiratory Volume in 1 Second (FEV1) before and after ARNUITY administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in the asthma symptom control results before and after ARNUITY administration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Force pounds lifted post-median sternotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at Sessions for Duration of Intervention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of Hospital Re-admissions/Emergency Room (ER) visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Daily Rhinoconjunctivitis Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Rhinoconjunctivitis Rescue Medication Score
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to reintervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative wound pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infusion-Related Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement of recommended Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival rate at 10 months
Endpoint domain: Mortality/survival
Primary endpoint: Composite Cancer Screening Tests up to Date
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HPV Vaccination up to Date
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Osteoarthritis Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum triacylglycerol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Total Opioid Consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants with SNPs variation of catechol-O-methyltransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with SNPs variation of monoamine oxidase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with SNPs variation of dopamine B hydroxylase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with SNPs variation of dopamine receptor 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with SNPs variation of brain-derived neurotropic factor genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presedation behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriate ICD Shock Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anti-tachycardia Pacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Resuscitated Sudden Cardiac Death
Endpoint domain: Mortality/survival
Primary endpoint: Development of Grade 1+ Lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morning Peak Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Korean Attention Deficit Hyperactivity Disorder rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Global Impression Scale-Severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's Global Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful bile duct cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Blood concentrations of tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Tolerance to repetitive stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Control rates of Nausea and Vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response rates of Vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea and Vomiting visual analogic scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased HIV care utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: detection of flap complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Eligible Patients Participating
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Med-South Lifestyle Program Delivered as Intended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of successful collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suspension of Insulin Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Restoration of insulin delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Agreement between algorithm-recommended pump action
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of alcohol-exposed pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of nicotine-exposed pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: HIV risk
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants completing laboratory sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of virtual reality exposure sessions completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Occurrence and severity of simulator sickness
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants completing the tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DAS28-CRP Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of follow-up appointments
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rate of Participants Experiencing Real-World Safety Data Events
Endpoint domain: Adverse events/effects
Primary endpoint: Heart Rate Variability (HRV) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: D1 Receptor Occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global disability on modified Rankin scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity for Classifier results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for MCT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power grip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drop in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: metabolite concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Episodes of Catheter Related Blood Stream Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in knee joint load during walking: knee adduction moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in the Level of Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change of retinal nerve fiber layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of IFN-γ and IL-4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of Treatment
Endpoint domain: Physiological/clinical
Primary endpoint: Radiographic bone volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Preeclampsia/Pregnancy Induced Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Gestational Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Large for Gestational Age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Mean Change in International Prostate Symptom Score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sizes of plaque areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to topical triamcinolone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of the severity of functional dyspepsia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient's global assessment of efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of pain and/or fullness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Harmonicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decision Conflict
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prostate Cancer Symptom Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptions of Partner's Drinking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concern about Partner's Drinking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relationship Quality
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Vital parameters correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 99th percentile for Troponin results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with liver decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Seizure
Endpoint domain: Adverse events/effects
Primary endpoint: Adjudicated Composite Rate of All Death, All MI and Target Vessel Revascularization (TVR)
Endpoint domain: Mortality/survival
Primary endpoint: long-term use of galantamine and nootropics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Identified Inflammatory Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Resolution of Contextual Red Flags
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in daily stool consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent Successful Data Transmissions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of Life as Measured by Kansas City Cardiomyopathy Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of participants with clinically significant ADRs of special interest
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with adverse drug reactions (ADRs) and serious adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of TNFα concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Variation of International Knee Documentation Committee (IKDC) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: immune cell surface marker expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: phagocytic ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endoscopic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lesional size estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of successful titration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global pleasure of inhalation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptom cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in inflammatory lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute Relative Difference (ARD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Treatment Emergent Serious Adverse Events
Endpoint domain: Adverse events/effects